Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-26-159585
Filing Date
2026-04-16
Accepted
2026-04-16 18:58:14
Documents
12
Effectiveness Date
2026-04-16

Document Format Files

Seq Description Document Type Size
1 S-1MEF d110326ds1mef.htm S-1MEF 32680
2 EX-23.1 d110326dex231.htm EX-23.1 1741
3 EX-FILING FEES d110326dexfilingfees.htm   iXBRL EX-FILING FEES 17868
  Complete submission text file 0001193125-26-159585.txt   175787

Data Files

Seq Description Document Type Size
15 EXTRACTED XBRL INSTANCE DOCUMENT d110326dexfilingfees_htm.xml XML 4733
Mailing Address 180 THIRD AVENUE 4TH FLOOR WALTHAM MA 02451
Business Address 180 THIRD AVENUE 4TH FLOOR WALTHAM MA 02451 508-440-9475
Kailera Therapeutics, Inc. (Filer) CIK: 0002096997 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-295114 | Film No.: 26868907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)